The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The Generation Of High Quality Evidence In Critical Care Medicine Through Multicentre Randomized Controleld Trials And Its Translation Into Practice
Funder
National Health and Medical Research Council
Funding Amount
$240,121.00
Summary
This research program will establish new approaches to sepsis, traumatic brain injury, kidney protection, transfusion, post-operative care, sedation, antibiotics and mobilization of acutely ill patients. Experimental research will help understand why the kidney malfunctions during severe infection. Database investigations will identify of successful patterns of treatment and potential new fields of investigations. Informatics based studies will use electronic data to develop decision support sys ....This research program will establish new approaches to sepsis, traumatic brain injury, kidney protection, transfusion, post-operative care, sedation, antibiotics and mobilization of acutely ill patients. Experimental research will help understand why the kidney malfunctions during severe infection. Database investigations will identify of successful patterns of treatment and potential new fields of investigations. Informatics based studies will use electronic data to develop decision support systems to improve patient care.Read moreRead less
Individual Patient Data Meta-analysis Of Randomised Control Trials In Fluid Resuscitation
Funder
National Health and Medical Research Council
Funding Amount
$85,027.00
Summary
I am a registered nurse focused in critical care research. I have an interest in the area of fluid resuscitation. My aim is to carry out an individual patient data meta-analysis (IPDMA) on randomised controlled trials (RCTs) in fluid resuscitation. The IPDMA will consist of two of the largest critical care trials; Saline Vs Albumin fluid Evaluation (SAFE) study and the Crystalloid Vs Starch (CHEST) study, to add further evidence to the currently limited fluid resuscitation literature.
A Centre For Research Excellence To Transform Outcomes Of Critically Ill Patients In ICU (CRE-ICU)
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
Patients who are admitted to intensive care (ICU) and require mechanical ventilation for life support account for 63,000 ICU admissions and 8,190 deaths each year in Australia, higher than the national road toll. CRE-ICU will transform outcomes for these patients by using data within registries and electronic medical records to perform high-impact, low cost clinical trials, generating new knowledge to inform national guidelines and policies and training the next generation of researchers.
Optimising Nutrient Delivery And Absorption In Critically Ill Patients
Funder
National Health and Medical Research Council
Funding Amount
$560,715.00
Summary
Patients surviving ICU are frequently discharged malnourished. Adequate nutrition is essential for optimal outcomes. It is considered best practice to administer nutrition as a liquid formula via a tube passed through the nose into the stomach, however this is frequently limited by impaired gastrointestinal function. We aim to develop more effective strategies for the provision of nutrition to improve nutritional and thereby clinical outcomes in critically ill patients.
Predicting The Risk Of Invasive Candidiasis In Critically Ill Patients
Funder
National Health and Medical Research Council
Funding Amount
$1,258,287.00
Summary
Invasive fungal infections (such as bloodstream infections) are a serious and increasing problem for critically ill patients managed in the Intensive Care Unit. Outcomes can be improved by giving early treatment only to those at highest risk of fungal infection. Our aim is to easily identify those at high-risk. Patients treated in seven major ICUs will be observed and a simple and accurate method of scoring their illness characteristics and amount-types of fungi present will be developed.
Optimising Transfusion Support In Critical Illness And Haematological Malignancies
Funder
National Health and Medical Research Council
Funding Amount
$262,251.00
Summary
Blood transfusion is commonly used for patient care. Improving our understanding about how to best use blood and blood products and finding ways to reduce the need for transfusion have been identified as important areas of national research. This fellowship aims to investigate interventions to reduce bleeding and the need for transfusion and improve the use of blood transfusion in two patients groups who are major users of blood: critically ill patients and patients with blood cancers.
The Cost-effectiveness Of Early Resuscitation Of Sepsis In Australia - An Economic Evaluation Alongside The ARISE-RCT
Funder
National Health and Medical Research Council
Funding Amount
$115,971.00
Summary
Critical care treatment is expensive and consumes a significant portion of hospital resources. This study will collect cost, survival and quality of life data on a group of sepsis patients enrolled in a trial of strict protocolised treatment versus standard care (the ARISE study). This information will be used to determine how much it costs for each additional survivor with protocolised treatment, and how much it costs for each quality adjusted life year gained with protocolised treatment.
Re-EValuating The Inhibition Of Stress Erosions (REVISE): Gastrointestinal Bleeding Prophylaxis In ICU
Funder
National Health and Medical Research Council
Funding Amount
$2,955,164.00
Summary
Around 50,000 patients in Australian Intensive Care Units receive a drug called pantoprazole each year with the aim of preventing bleeding from the gut. Recent research suggests this practice is ineffective and may harm patients by increasing their risk of serious infections. We will perform a definitive study to determine whether the widespread use of pantoprazole is beneficial or harmful.
Management Of Refeeding Syndrome In Critical Illness: An AuSPEN Endorsed Multi-centre Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,366,987.00
Summary
Critically ill hospitalised patients are frequently malnourished. When feeding is reestablished in malnourished patients, they often exhibit severe electrolyte imbalances and metabolic disturbances that can lead to slower recovery times, increased complications and even death. The purpose of this clinical trial is to investigate the benefits of a conservative approach of managing critically ill patients with refeeding syndrome.
Optimisation By Platform Trial Involving Multiple Interventions With Simultaneous Evaluation In Community Acquired Pneumonia (OPTIMISE-CAP)
Funder
National Health and Medical Research Council
Funding Amount
$4,413,145.00
Summary
In Australia severe Community Acquired Pneumonia is responsible for more than 7000 ICU admissions and 1400 deaths each year. This trial will determine the optimal treatments among existing choices of therapy related to choice of antibiotic, ventilator strategy and modulation of the immune system. The trial uses new methods to answer more research questions as quickly as possible.